You are here: Industry Insights > Pfizer

News List

Pfizer to launch consumer health sale in November: Sources expressbpd
October 27, 2017
Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters.
Pfizer to begin auction of consumer health division next month pharmafile
October 27, 2017
Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that the pharma giant is planning to launch an auction process to secure its sale and the $15 billion-plus it is looking for for t
The Union for International Cancer Control and Pfizer award new round of grants totalling US$500,000 worldpharmanews
October 24, 2017
The Union for International Cancer Control (UICC) and Pfizer Oncology have announced the names of the organisations taking part in the second phase of the Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge
Pfizer’s lorlatinib impresses in Phase II lung cancer trial pharmatimes
October 18, 2017
Pfizer has presented Phase II data showing that its next-generation tyrosine kinase inhibitor lorlatinib exhibited “clinically meaningful activity” against lung tumours and brain metastases.
Pfizer seeking options for the future of its consumer health business pharmatimes
October 12, 2017
Pfizer says it is considering the future of its massive consumer health division, with options including a full or partial separation of the business through a spin-off, sale or other transaction, or keeping hold of the unit.
Pfizer reviewing strategic alternatives for consumer healthcare division biospectrumasia
October 12, 2017
A range of options will be considered, including a full or partial separation of the Consumer Healthcare business from Pfizer
Lilly steps up to rival Pfizer, Novartis with Verzenio breast cancer approval fiercepharma
September 29, 2017
For the second time in just over six months, there’s a newcomer in a next-generation class of breast cancer-fighters.
Pfizer spins out biotech firm with $103 million in funding biospectrumasia
September 27, 2017
Pfizer spins out biotech firm with $103 million in funding Over the past decade, many Pfizer drugs have found success outside the company.
Pfizer, Merck KGaA grab EU approval for PD-L1 Bavencio in Merkel cell carcinoma fiercepharma
September 22, 2017
Pfizer and Merck KGaA’s new immuno-oncology drug Bavencio, which won an FDA nod for Merkel cell carcinoma in March, is now approved in Europe to treat the aggressive type of skin cancer.
Pfizer files lawsuit against J&J’s exclusionary contracts for Remicade pharmaceufical-technology
September 22, 2017
Pfizer has filed a lawsuit against Johnson & Johnson (J&J) in the US District Court for the Eastern District of Pennsylvania to ensure patients and providers have access to major, lower-cost biosimilar therapies.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page